If an American hasn’t been vaccinated for COVID-19 yet, they likely don’t want to be. Unless they’re a child, or course. However, that will change very soon. According to a recent Stat News article, the FDA expanded the emergency use authorization of Pfizer’s vaccine to include children ages 12 to 15. The decision was linked to a Phase 3 trial that proved the vaccine is both safe and effective in that age group.
Pfizer announced in April that it had applied for a similar eligibility expansion with the European Medicines Agency, and Health Canada expanded the emergency use provision last two weeks ago. Moderna and Johnson and Johnson aren’t too far behind though. Moderna is testing its vaccine in children aged 12 to 18, and Johnson and Johnson announced in early April it had begun testing in the same age group.